Context: This study aimed to evaluate the feasibility of an advance directive (AD) at the time of starting first-line palliative chemotherapy. We investigated changes in emotional distress, quality of life (QoL), and attitudes toward anticancer treatments between before and after AD.
Methods: Patients with advanced cancer who had just started palliative chemotherapy were prospectively enrolled.